EVAMIST Drug Patent Profile
✉ Email this page to a colleague
When do Evamist patents expire, and what generic alternatives are available?
Evamist is a drug marketed by Padagis Us and is included in one NDA.
The generic ingredient in EVAMIST is estradiol. There are seventy-five drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the estradiol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Evamist
A generic version of EVAMIST was approved as estradiol by BARR LABS INC on October 22nd, 1997.
Summary for EVAMIST
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 109 |
Clinical Trials: | 1 |
Patent Applications: | 4,323 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for EVAMIST |
Drug Sales Revenues: | Drug sales revenues for EVAMIST |
What excipients (inactive ingredients) are in EVAMIST? | EVAMIST excipients list |
DailyMed Link: | EVAMIST at DailyMed |
![EVAMIST drug patent expirations Drug patent expirations by year for EVAMIST](/p/graph/s/t/EVAMIST-patent-expirations.png)
![Drug Prices for EVAMIST](/p/graph/drug-price/EVAMIST.png)
![Drug Sales Revenue Trends for EVAMIST](/p/graph/drug-sales-revenues/EVAMIST.png)
Recent Clinical Trials for EVAMIST
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Lumara Health, Inc. | Phase 3 |
Pharmacology for EVAMIST
Drug Class | Estrogen |
Mechanism of Action | Estrogen Receptor Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for EVAMIST
US Patents and Regulatory Information for EVAMIST
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Padagis Us | EVAMIST | estradiol | SPRAY;TRANSDERMAL | 022014-001 | Jul 27, 2007 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for EVAMIST
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Padagis Us | EVAMIST | estradiol | SPRAY;TRANSDERMAL | 022014-001 | Jul 27, 2007 | ⤷ Sign Up | ⤷ Sign Up |
Padagis Us | EVAMIST | estradiol | SPRAY;TRANSDERMAL | 022014-001 | Jul 27, 2007 | ⤷ Sign Up | ⤷ Sign Up |
Padagis Us | EVAMIST | estradiol | SPRAY;TRANSDERMAL | 022014-001 | Jul 27, 2007 | ⤷ Sign Up | ⤷ Sign Up |
Padagis Us | EVAMIST | estradiol | SPRAY;TRANSDERMAL | 022014-001 | Jul 27, 2007 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for EVAMIST
See the table below for patents covering EVAMIST around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Australia | 2005234689 | ⤷ Sign Up | |
European Patent Office | 1345549 | ⤷ Sign Up | |
South Korea | 100831386 | ⤷ Sign Up | |
Australia | 706967 | ⤷ Sign Up | |
Portugal | 1674068 | ⤷ Sign Up | |
Japan | 4213211 | ⤷ Sign Up | |
Denmark | 1769785 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for EVAMIST
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0398460 | 04C0022 | France | ⤷ Sign Up | PRODUCT NAME: ESTRADIOL ANHYDRE DROSPIRENONE; REGISTRATION NO/DATE IN FRANCE: NL 28661 DU 20040316; REGISTRATION NO/DATE AT EEC: RVG 27505 DU 20021211 |
2782584 | 132021000000197 | Italy | ⤷ Sign Up | PRODUCT NAME: ESTRADIOLO (17SS-ESTRADIOLO) IN PARTICOLARE NELLA FORMA EMIIDRATA, E PROGESTERONE COMPRENDENTI LE VARIE FORME DI ESTRADIOLO (17SS-ESTRADIOLO), QUALI LE FORME IDRATE E SOLVATATE, INCLUDENDO LA FORMA EMIIDRATA, ED I SUOI SALI.(BIJUVA); AUTHORISATION NUMBER(S) AND DATE(S): BE582231, 20210406;048335018 -048335020, 20210517 |
1453521 | C201630040 | Spain | ⤷ Sign Up | PRODUCT NAME: ETINILESTRADIOL Y MEZCLA DE LEVONORGESTREL Y ETINILESTRADIOL; NATIONAL AUTHORISATION NUMBER: 80340; DATE OF AUTHORISATION: 20160122; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): 17/0017/15-S; DATE OF FIRST AUTHORISATION IN EEA: 20150211 |
1453521 | 39/2015 | Austria | ⤷ Sign Up | PRODUCT NAME: ETHINYLESTRADIOL UND EINE KOMBINATION VON LEVONORGESTREL UND ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: 136021 20150224; FIRST REGISTRATION: SK 17/0017/15-S 20150211 |
1214076 | C01214076/01 | Switzerland | ⤷ Sign Up | PRODUCT NAME: DROSPIRENONE + ETHINYLESTRADIOL; REGISTRATION NUMBER/DATE: SWISSMEDIC 57946 13.06.2008 |
1380301 | 2009C/007 | Belgium | ⤷ Sign Up | PRODUCT NAME: DROSPIRENONE-ETHINYLESTRADIOL; AUTHORISATION NUMBER AND DATE: BE321386 20080811 |
0770388 | SPC/GB09/026 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: ESTRADIOL AND COMBINATIONS OF ESTRADIOL AND DIENOGEST, PREFERABLY ESTRADIOL VALERATE AND COMBINATIONS OF ESTRADIOL VALERATE AND DIENOGEST; REGISTERED: BE BE 327792 20081103; UK PL 00010/0576-0001 20081208 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |